SCHEMBL4020068

SCHEMBL4020068

O=C(c1ccccc1)c1cc(Cl)ccc1CCCBr

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
HTT P42858 2/20 0.47
NPSR1 Q6W5P4 2/20 0.47
MITF O75030 1/20 0.47
HSP90AA1 P07900 1/20 0.47
ATM Q13315 1/20 0.47
TLR9 Q9NR96 1/20 0.47
TP53 P04637 2/20 0.46
GABRP O00591 1/20 0.46
GABRD O14764 1/20 0.46
GABRA1 P14867 1/20 0.46
GABRB1 P18505 1/20 0.46
GABRG2 P18507 1/20 0.46
GABRB3 P28472 1/20 0.46
GABRA5 P31644 1/20 0.46
GABRA3 P34903 1/20 0.46
GABRA2 P47869 1/20 0.46
GABRB2 P47870 1/20 0.46
GABRA4 P48169 1/20 0.46
GABRE P78334 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11007812 0.86 GABRP (0.52) ALDH1A1HTTNPSR1MITFHSP90AA1
SCHEMBL11084165 0.82 ALDH1A1 (0.47) ALDH1A1HTTNPSR1MITFHSP90AA1
SCHEMBL27513043 0.80 GABRP (0.55) ALDH1A1HTTNPSR1MITFHSP90AA1
SCHEMBL10998695 0.79 TDP1 (0.55) ALDH1A1HTTNPSR1MITFHSP90AA1
SCHEMBL13316485 0.79 CYP3A4 (0.54) ALDH1A1HTTNPSR1MITFHSP90AA1
SCHEMBL11078643 0.79 ALDH1A1 (0.49) ALDH1A1HTTNPSR1MITFHSP90AA1
SCHEMBL2991425 0.78 PTGDR2 (0.51) ALDH1A1HTTNPSR1MITFHSP90AA1
SCHEMBL11037117 0.75 MAPT (0.50) ALDH1A1HTTNPSR1MITFHSP90AA1
SCHEMBL28157462 0.74 NR4A1 (0.61) ALDH1A1HTTNPSR1MITFHSP90AA1
SCHEMBL11076174 0.74 CYP2C8 (0.50) ALDH1A1HTTNPSR1MITFHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2061795-B1 PYRROLO[2,1-C][1,4]BENZODIAZEPINE HYBRIDS AND A PROCESS FOR THE PREPARATION THEREOF COUNCIL SCIENT IND RES (IN) 2014-01-15 EP disclosed
EP-2061795-A2 PYRROLO[2,1-C][1,4]BENZODIAZEPINE HYBRIDS AND A PROCESS FOR THE PREPARATION THEREOF Council Of Scientific&industrial Research (IN) 2009-05-27 EP disclosed
US-7528128-B2 Pyrrolo[2,1-C][1,4]benzodiazepine hybrids and a process for the preparation thereof COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2009-05-05 US disclosed
US-20080064870-A1 Pyrrolo[2,1-C][1,4]benzodiazepine hybrids and a process for the preparation thereof COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2008-03-13 US disclosed
WO-2008020455-A2 PYRROLO[2,1-C][1,4]BENZODIAZEPINE HYBRIDS AND A PROCESS FOR THE PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2008-02-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064870-A1 Pyrrolo[2,1-C][1,4]benzodiazepine hybrids and a process for the preparation thereof CYP11B1, CYP11B2, GABRA5 ALDH1A1 1083/4885HTT 3952/4885NPSR1 198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.